Unknown

Dataset Information

High expression of ANRIL correlated with the poor prognosis in patients with cancer: A meta-analysis.


ABSTRACT:

Background

ANRIL, also called CDKN2B antisense RNA 1, is an important genetic susceptibility locus for cardiovascular diseases and associated with numerous pathologies, including several human cancers.

Objective

The relationship between ANRIL and the clinical outcome or prognosis of cancer patients was analyzed in this meta-analysis.

Methods

One thousand seven hundred eight cancer patients were selected in 23 studies from 3 databases (Pubmed, Cochrane Library, and EMBASE).

Results

A fixed-effects model indicated that the high expression of ANRIL is obviously linked to poor overall survival (OS) (Hazard ratio [HR] = 1.77, 95% confidence interval [CI] = 1.57-2.00, P < .00001); the random-effects model revealed poor disease-free survival (DFS) (HR = 1.86, 95% CI:

SUBMITTER: Liu Y 

PROVIDER: S-EPMC10980395 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature